These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


155 related items for PubMed ID: 9256889

  • 1. Results of re-irradiation of primary intracranial neoplasms with three-dimensional conformal therapy.
    Kim HK, Thornton AF, Greenberg HS, Page MA, Junck L, Sandler HM.
    Am J Clin Oncol; 1997 Aug; 20(4):358-63. PubMed ID: 9256889
    [Abstract] [Full Text] [Related]

  • 2. Radiotherapy in supratentorial gliomas. A study of 821 cases.
    Heesters M, Molenaar W, Go GK.
    Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
    [Abstract] [Full Text] [Related]

  • 3. [Malignant gliomas--radiotherapy].
    Schratter-Sehn A.
    Wien Med Wochenschr; 2006 Jun; 156(11-12):342-5. PubMed ID: 16944365
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL, Weber WA, Franz M, Stärk S, Piert M, Thamm R, Gumprecht H, Schwaiger M, Molls M, Nieder C.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):511-9. PubMed ID: 16168843
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.
    Minniti G, Amelio D, Amichetti M, Salvati M, Muni R, Bozzao A, Lanzetta G, Scarpino S, Arcella A, Enrici RM.
    Radiother Oncol; 2010 Dec 01; 97(3):377-81. PubMed ID: 20855119
    [Abstract] [Full Text] [Related]

  • 10. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
    Bahri S, Flickinger JC, Kalend AM, Deutsch M, Belani CP, Sciurba FC, Luketich JD, Greenberger JS.
    Radiat Oncol Investig; 1999 Dec 01; 7(5):297-308. PubMed ID: 10580899
    [Abstract] [Full Text] [Related]

  • 11. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)].
    Afra D, Sipos L, Vitanovics D.
    Ideggyogy Sz; 2002 Jan 20; 55(1-2):38-44. PubMed ID: 12122942
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03.
    Tsien C, Moughan J, Michalski JM, Gilbert MR, Purdy J, Simpson J, Kresel JJ, Curran WJ, Diaz A, Mehta MP, Radiation Therapy Oncology Group Trial 98-03.
    Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):699-708. PubMed ID: 18723297
    [Abstract] [Full Text] [Related]

  • 14. Stereotactic radiosurgery for recurrent gliomas.
    Chamberlain MC, Barba D, Kormanik P, Shea WM.
    Cancer; 1994 Aug 15; 74(4):1342-7. PubMed ID: 8055458
    [Abstract] [Full Text] [Related]

  • 15. Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation.
    Combs SE, Ahmadi R, Schulz-Ertner D, Thilmann C, Debus J.
    J Neurooncol; 2005 Feb 15; 71(3):319-23. PubMed ID: 15735924
    [Abstract] [Full Text] [Related]

  • 16. Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study.
    Fulton DS, Urtasun RC, Scott-Brown I, Johnson ES, Mielke B, Curry B, Huyser-Wierenga D, Hanson J, Feldstein M.
    J Neurooncol; 1992 Sep 15; 14(1):63-72. PubMed ID: 1335044
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma.
    Deutsch M, Green SB, Strike TA, Burger PC, Robertson JT, Selker RG, Shapiro WR, Mealey J, Ransohoff J, Paoletti P.
    Int J Radiat Oncol Biol Phys; 1989 Jun 15; 16(6):1389-96. PubMed ID: 2542193
    [Abstract] [Full Text] [Related]

  • 19. Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study.
    Lee SW, Fraass BA, Marsh LH, Herbort K, Gebarski SS, Martel MK, Radany EH, Lichter AS, Sandler HM.
    Int J Radiat Oncol Biol Phys; 1999 Jan 01; 43(1):79-88. PubMed ID: 9989517
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.